This second volume chronicles the later stages of the outbreak of SARS-Cov-2 (COVID-19) and delineates the role of several disciplines in therapeutic and control measures highlighting the response from specific countries of note and efforts to repurpose and produce new therapeutics and vaccines. By addressing considerations of efficacy and safety of drugs and chemicals used to combat COVID-19, virtually in real-time, this book documents and highlights the advances in science and place the toxicology, pharmaceutical science, public health and medical community in a better position to advise in future epidemics.

• Chronicles Later Stages of COVID-19 Outbreak: Focuses on the continued global response to the pandemic as it progressed.
• Interdisciplinary Contributions: Highlights the role of various disciplines, including toxicology, pharmaceutical science, public health, and medicine, in combating COVID-19.
• Country-Specific Responses: Examines the strategies and efforts of specific countries in addressing the pandemic.
• Repurposing and Developing New Therapies: Documents efforts to repurpose existing drugs and develop new therapeutics and vaccines to combat COVID-19.
• Real-Time Evaluation: Discusses the efficacy and safety of drugs and chemicals used during the pandemic, providing insights into decision-making in real-time.
• Advances in Science: Tracks key scientific advancements in therapeutics, vaccines, and public health strategies.
• Future Preparedness: Aims to position the medical, toxicology, pharmaceutical, and public health communities better for advising and responding to future epidemics.